Control of pandemic (H1N1) 2009 influenza virus infection of ferret lungs by non-adjuvant-containing pandemic and seasonal vaccines

Vaccine

Volumn 30, Issue 24, 2012, Pages 3618-3623

  Rockman, Steven ^a   Middleton, Deborah J ^b   Pearse, Martin J ^a   Barr, Ian G ^c   Lowther, Sue ^b   Brown, Lorena E ^d  

^a CSL LIMITED   (Australia)

^b Australian Animal Health Laboratory   (Australia)

^c WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Influenza; Pandemic; Seasonal; Vaccine unadjuvanted

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; FEMALE; FERRET; INFLUENZA VACCINATION; INOCULATION; LUNG PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; VIRUS LOAD; WILD TYPE;

ANIMALS; FEMALE; FERRETS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; LUNG; MALE; VIRAL LOAD; VIRUS SHEDDING;

EID: 84861001572     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.03.043     Document Type: Article

References (19)

1. Bautista E., Chotpitayasunondh T., Gao Z., Harper S.A., Shaw M., Uyeki T.M., et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010, 362:1708-1719.
2. Itoh Y., Shinya K., Kiso M., Goto H., Takahashi K., Makino A., et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460:1021-1025.
3. Nolan T., McVernon J., Skeljo M., Richmond P., Wadia U., Lambert S., et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in infants and children: a randomized trial. JAMA 2010, 303:37-46.
4. ®: a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009. Expert Rev Vaccines 2011, 10:35-43.
5. Coulter A., Wong T.Y., Drane D., Bates J., Macfarlan R., Cox J. Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines. Vaccine 1998, 16:1243-1253.
6. Middleton D., Rockman S., Pearse M., Barr I., Lowther S., Klippel J., et al. Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization. J Virol 2009, 83:7770-7778.
7. Munster V.J., de Wit E., van den Brand J.M., Herfst S., Schrauwen E.J., Bestebroer T.M., et al. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 2009, 325:481-483.
8. Del Giudice G., Stittelaar K.J., van Amerongen G., Simon J., Osterhaus A.D., Stohr K., et al. Seasonal influenza vaccine provides priming for A/H1N1 immunization. Sci Transl Med 2009, 1:12re1.
9. Baras B., de Waal L., Stittelaar K.J., Jacob V., Giannini S., Kroeze E.J., et al. Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naive ferrets. Vaccine 2011, 29:2120-2126.
10. Laurie K.L., Carolan L.A., Middleton D., Lowther S., Kelso A., Barr I.G. Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. J Infect Dis 2010, 202:1011-1020.
11. Kobinger G.P., Meunier I., Patel A., Pillet S., Gren J., Stebner S., et al. Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus. J Infect Dis 2010, 201:1000-1006.
12. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361:1945-1952.
13. Ellebedy A.H., Ducatez M.F., Duan S., Stigger-Rosser E., Rubrum A.M., Govorkova E.A., et al. Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets. Vaccine 2011, 29:3335-3339.
14. Brown L.E., Kelso A. Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes. Immunol Cell Biol 2009, 87:300-308.
15. McMichael A.J., Gotch F.M., Noble G.R., Beare P.A. Cytotoxic T-cell immunity to influenza. N Engl J Med 1983, 309:13-17.
16. Chen G.L., Min J.Y., Lamirande E.W., Santos C., Jin H., Kemble G., et al. Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets. J Infect Dis 2011, 203:930-936.
17. Okuno Y., Isegawa Y., Sasao F., Ueda S. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol 1993, 67:2552-2558.
18. Throsby M., van den Brink E., Jongeneelen M., Poon L.L., Alard P., Cornelissen L., et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 2008, 3:e3942.
19. Corti D., Suguitan A.L., Pinna D., Silacci C., Fernandez-Rodriguez B.M., Vanzetta F., et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest 2010, 120:1663-1673.